2007 Annual Meeting | Using AAN Guidelines and Best Current Evidence in Daily Practice: Stroke

Date Saturday 04/28/07

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Gary S. Gronseth, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to distinguish rhetorical from reason-based arguments commonly used in neurology; assess whether any published study provides strong or weak evidence for answering controversial questions; understand the ways in which methodological quality is assessed for therapeutic, diagnostic, and prognostic studies; and understand the evidence surrounding controversies in stroke management.

CME Available No CME available

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 03:00 PM		The AAN's Guideline Development Process: Stroke Risk in Patent Foramen Ovale Gary S. Gronseth, MD, FAAN
03:00 PM - 03:45 PM		Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke Larry B. Goldstein, MD, FAHA, FAAN
03:45 PM - 04:00 PM		Break
04:05 PM - 04:50 PM		Carotid Endarterectomy Seemant Chaturvedi, MD, FAHA, FAAN
04:50 PM - 05:35 PM		Anticoagulants for Cerebral Vein Thrombosis Rima Dafer, MD
05:35 PM - 06:00 PM		Discussion

Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.

��ɫ��

��ɫ��